the market?
Codexis
NASDAQ: CDXS
2.61
-0.05
(-1.88%)
| Today's Open | $2.66 |
|---|---|
| Previous Close | $2.66 |
| Daily Range | $2.47 - $2.69 |
| 52-Week Range | $1.99 - $4.00 |
| Market Cap | $99.2M |
| P/E Ratio | -3.02 |
| Dividend (Yield) | $0.00 (0.0%) |
| Volume | 257,206 |
| Average Daily Volume | 208,224 |
| Current FY EPS | -$1.21 |
How do you think CDXS
will perform against the market?
Top CDXS Bull/Bear Pitches
News & Commentary
Gevo Begins Countdown to Ethanol's End
A Fool breaks down the latest announcement from industrial biotech company Gevo.Codexis and Chemtex Achieve Key Milestone in Commercial Development of Bio-Based Chemicals from Non-
World's Largest Chemical Company Makes a Splash in Enzymes
BASF barreled into industrial enzymes with three big developments. Does that spell disaster or opportunity for Codexis?Has This New Biotech Industry Learned Its Lesson?
A Fool prepares investors for potential positive surprises in the industrial biotech industry.5 Best Stocks to Invest in Industrial Biotech
A Fool recaps the best current stocks to expose your portfolio to the industrial biotechnology industry.This Biotech Stock Keeps Investors Patiently Waiting
What investors need to know about first-quarter earnings from Codexis.Sector
Healthcare
Industry
Drugs
Codexis (CDXS) Description
Codexis is a biotech company trying to turn cellulosic biomass into fuel. It was spun off from Maxygen in 2010. Website: http://www.codexis.com/
More details for Codexis Jobs
Codexis reviews from employees
